Page 48 - Merck Sharp News Today

Operator: Q4 Sales and Earnings Conference Call. At this time, all participants are on a listen-only mode until the question-and-answer session of todays conference. This call is being recorded.

Where a plaintiff has brought suit alleging that she incurred neuropsychiatric injuries after ingesting a prescription pharmaceutical product, the plaintiff’s negligent design claims are preempted and therefore must be dismissed. “Plaintiff Amy Licht (‘Plaintiff’ or ‘Licht’) brings the instant action against Merck & Co., Inc., Merck Sharp & Dohme Corp., Organon & Co., and Organon,

Nearly one in five cancer clinical trial enrolment sites surveyed worldwide failed to enrol more than one patient, according to a new report.

Investegate announcements from 4d Pharma PLC, Updated Results from Renal Cell Carcinoma Cohort

The FDA announced the changes Wednesday in letters sent to the drugs manufacturers, Pfizer and Merck.

Today's post is a little different in its format from what our readers are used to. What follows is a lightly edited (primarily adding full…

The Indonesian government officially announced the revocation of its public activity restrictions (PPKM) policy on December 30, 2022. The revocation ...

Kristian F. Axelsson and colleagues investigate fracture risk in patients with type 2 diabetes and seek to identify relevant risk factors.

Kristian F. Axelsson and colleagues investigate fracture risk in patients with type 2 diabetes and seek to identify relevant risk factors.

In patients with advanced refractory gastroesophageal cancer who had tried two other options, regorafenib improved overall survival when compared with placebo, offering a potential new treatment option.